Onco-Innovations Appoints Dr. John Mackey to Scientific & Clinical Advisory Board
VANCOUVER, BC / ACCESS Newswire / September 5, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased...
Clinical Trial
Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need
~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse range of participants with uncontrolled or resistant hypertension~...
Palisade Bio Receives Health Canada Clearance for Phase 1b Trial of PALI-2108 in Fibrostenotic Crohn’s Disease (FSCD)
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Patient dosing expected to...
Trump’s DEA Must Choose: Reward Illegal Marijuana Operators or Sanction Science?
As the Trump administration cracks down on foreign drug cartels, MMJ BioPharma Cultivation exposes a hypocritical domestic policy: rewarding illegal...
Global Working Group Releases Publication on Responsible Use of Artificial Intelligence in Creating Lay Summaries of Clinical Trial Results
New publication underscores the importance of human oversight, transparency, and patient involvement in AI-assisted lay summaries. BOSTON, Sept. 4, 2025...
Global Working Group Releases Publication on Responsible Use of Artificial Intelligence in Creating Lay Summaries of Clinical Trial Results
New publication underscores the importance of human oversight, transparency, and patient involvement in AI-assisted lay summaries. BOSTON, Sept. 4, 2025...
New Study Boosts Trial Precision in Measuring Pain, Mood, and Fatigue
Published in the Journal of Pain, Cognivia's research brings more objectivity to pain trials, leading to cleaner data, smarter decisions,...
One2Treat raises capital to further accelerate software platform development and relocates offices to support rapid growth
LOUVAIN-LA-NEUVE, Belgium, Sept. 4, 2025 /PRNewswire/ -- One2Treat SA, a fast-growing technology company transforming how the patient voice is integrated into clinical...
Xtalks Announces its Life Science Webinar Calendar for September 2025
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, biotech, cell and gene therapy, clinical trials, drug discovery &...
Hoth Therapeutics Taps Lantern Pharma’s PredictBBB.ai Platform — Breakthrough AI With 94% Accuracy Driving Next-Gen Drug Development
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced that it...
Waterdrop Inc. Announces Second Quarter 2025 Unaudited Financial Results and a Cash Dividend
BEIJING, Sept. 4, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated...
Hemostemix’s VesCell.Health Launched in Florida
Calgary, Alberta--(Newsfile Corp. - September 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...
Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules
New candidates, APVO452 and APVO451, harness proprietary ADAPTIR-FLEXTM design to target prostate and multiple solid tumor cancers by simultaneously engaging...
Tenon(R) Medical Announces Second Peer-Reviewed Catamaran Mainsail(TM) Study Publication, Underscores Robust and Sustainable Clinical Outcomes Out to 12 Months
~ Clinically Significant Patient Outcomes Demonstrate Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety...
Ensysce Biosciences Showcases Urgent Need for Safer Opioids at PAINWeek 2025 Symposium
~ Experts Spotlight TAAP™ and MPAR® as Next-Generation Solutions for Severe Pain ~ SAN DIEGO, CA / ACCESS Newswire /...
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment
Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses the Company’s recently announced results from the post hoc analysis of...
Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson’s Disease
Novel human preclinical neuronal model for Parkinson’s disease demonstrated CNM-Au8’s ability to improve mitochondrial health, restore cellular metabolism, reduce inflammation,...
BiomX CEO to Present at H.C. Wainwright 27th Annual Global Investment Conference
Presentation to Focus on Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis...
IO Biotech Announces Participation in Upcoming Investor Conferences
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf...
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025
Totality of data supports potential for isaralgagene civaparvovec as a one-time, durable treatment of the underlying pathology of Fabry disease...